サマリー

養子細胞免疫とは、ドナーのリンパ球をレシピエントに移植し、その細胞性免疫を高めることです。

市場分析と洞察。アドプト細胞免疫療法の世界市場
アドプト細胞免疫療法の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX％のCAGRで、2027年にはXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の養子縁組免疫療法市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、収益面での世界のAdoptive Cellular Immunotherapy市場全体のサイズを含む、検証された信頼できる市場予測にアクセスすることができます。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の養子縁組免疫療法市場で永続的な成功を収めるために利用できる効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の養子縁組免疫療法市場を詳細に調査するために、ユニークで業界最高の調査・分析手法を用いています。

世界の養子縁組細胞免疫療法の範囲と市場規模
Adoptive Cellular Immunotherapy市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のAdoptive Cellular Immunotherapy市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
その他

用途別セグメント
病院
がん専門病院
疾病管理予防センター
リハビリテーションセンター
その他

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
アムジェン・インク
Autolus Therapeutics Plc
北京Immunochina Medical Science & Technology Co Ltd.
ベリカム・ファーマシューティカルズ・インク
ブリストル・マイヤーズ スクイブ株式会社
ブルーバード・バイオ株式会社
CARsgen Therapeutics Ltd.
セルジーン・コーポレーション
セルメディカ株式会社
セルラー・バイオメディシン・グループ社
セルラリティ・インク
Celyad SA
第一三共株式会社
Fosun Pharmaceutical AG
Gilead Sciences Inc.
広州安捷生物医学技術有限公司
杭州コンバード有限公司
河北専朗生物工学有限公司
HRAINバイオテクノロジー社
ジュノー・セラピューティクス社
カイト・ファーマ・インク
南京レジェンドバイオテック株式会社
NantKwest社
Nkarta Inc.
ノバルティスAG
小野薬品工業株式会社
上海聯合療法生物医薬技術有限公司
ソレント・セラピューティック社（Sorrento Therapeutics Inc.
タカラバイオ株式会社

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 TIL
1.2.3 LAK
1.2.4 CAR-T
1.2.5 TCR-T
1.2.6 CIK
1.2.7 NK
1.2.8 DC
1.2.9 Other
1.3 Market by Application
1.3.1 Global Adoptive Cellular Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Cancer Hospital
1.3.4 Centers for Disease Control and Prevention
1.3.5 Rehabilitation Center
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Adoptive Cellular Immunotherapy Market Perspective (2016-2027)
2.2 Adoptive Cellular Immunotherapy Growth Trends by Regions
2.2.1 Adoptive Cellular Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adoptive Cellular Immunotherapy Historic Market Share by Regions (2016-2021)
2.2.3 Adoptive Cellular Immunotherapy Forecasted Market Size by Regions (2022-2027)
2.3 Adoptive Cellular Immunotherapy Industry Dynamic
2.3.1 Adoptive Cellular Immunotherapy Market Trends
2.3.2 Adoptive Cellular Immunotherapy Market Drivers
2.3.3 Adoptive Cellular Immunotherapy Market Challenges
2.3.4 Adoptive Cellular Immunotherapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue
3.1.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue (2016-2021)
3.1.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Players (2016-2021)
3.2 Global Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cellular Immunotherapy Revenue
3.4 Global Adoptive Cellular Immunotherapy Market Concentration Ratio
3.4.1 Global Adoptive Cellular Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cellular Immunotherapy Revenue in 2020
3.5 Adoptive Cellular Immunotherapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cellular Immunotherapy Product Solution and Service
3.7 Date of Enter into Adoptive Cellular Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Adoptive Cellular Immunotherapy Breakdown Data by Type
4.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Type (2016-2021)
4.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Type (2022-2027)

5 Adoptive Cellular Immunotherapy Breakdown Data by Application
5.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Application (2016-2021)
5.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Adoptive Cellular Immunotherapy Market Size (2016-2027)
6.2 North America Adoptive Cellular Immunotherapy Market Size by Type
6.2.1 North America Adoptive Cellular Immunotherapy Market Size by Type (2016-2021)
6.2.2 North America Adoptive Cellular Immunotherapy Market Size by Type (2022-2027)
6.2.3 North America Adoptive Cellular Immunotherapy Market Size by Type (2016-2027)
6.3 North America Adoptive Cellular Immunotherapy Market Size by Application
6.3.1 North America Adoptive Cellular Immunotherapy Market Size by Application (2016-2021)
6.3.2 North America Adoptive Cellular Immunotherapy Market Size by Application (2022-2027)
6.3.3 North America Adoptive Cellular Immunotherapy Market Size by Application (2016-2027)
6.4 North America Adoptive Cellular Immunotherapy Market Size by Country
6.4.1 North America Adoptive Cellular Immunotherapy Market Size by Country (2016-2021)
6.4.2 North America Adoptive Cellular Immunotherapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Adoptive Cellular Immunotherapy Market Size (2016-2027)
7.2 Europe Adoptive Cellular Immunotherapy Market Size by Type
7.2.1 Europe Adoptive Cellular Immunotherapy Market Size by Type (2016-2021)
7.2.2 Europe Adoptive Cellular Immunotherapy Market Size by Type (2022-2027)
7.2.3 Europe Adoptive Cellular Immunotherapy Market Size by Type (2016-2027)
7.3 Europe Adoptive Cellular Immunotherapy Market Size by Application
7.3.1 Europe Adoptive Cellular Immunotherapy Market Size by Application (2016-2021)
7.3.2 Europe Adoptive Cellular Immunotherapy Market Size by Application (2022-2027)
7.3.3 Europe Adoptive Cellular Immunotherapy Market Size by Application (2016-2027)
7.4 Europe Adoptive Cellular Immunotherapy Market Size by Country
7.4.1 Europe Adoptive Cellular Immunotherapy Market Size by Country (2016-2021)
7.4.2 Europe Adoptive Cellular Immunotherapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size (2016-2027)
8.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type
8.2.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application
8.3.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region
8.4.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Adoptive Cellular Immunotherapy Market Size (2016-2027)
9.2 Latin America Adoptive Cellular Immunotherapy Market Size by Type
9.2.1 Latin America Adoptive Cellular Immunotherapy Market Size by Type (2016-2021)
9.2.2 Latin America Adoptive Cellular Immunotherapy Market Size by Type (2022-2027)
9.2.3 Latin America Adoptive Cellular Immunotherapy Market Size by Type (2016-2027)
9.3 Latin America Adoptive Cellular Immunotherapy Market Size by Application
9.3.1 Latin America Adoptive Cellular Immunotherapy Market Size by Application (2016-2021)
9.3.2 Latin America Adoptive Cellular Immunotherapy Market Size by Application (2022-2027)
9.3.3 Latin America Adoptive Cellular Immunotherapy Market Size by Application (2016-2027)
9.4 Latin America Adoptive Cellular Immunotherapy Market Size by Country
9.4.1 Latin America Adoptive Cellular Immunotherapy Market Size by Country (2016-2021)
9.4.2 Latin America Adoptive Cellular Immunotherapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size (2016-2027)
10.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type
10.2.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application
10.3.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country
10.4.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Adoptive Cellular Immunotherapy Introduction
11.1.4 Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.1.5 Amgen Inc Recent Development
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Details
11.2.2 Autolus Therapeutics Plc Business Overview
11.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Introduction
11.2.4 Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.2.5 Autolus Therapeutics Plc Recent Development
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Details
11.4.2 Bellicum Pharmaceuticals Inc Business Overview
11.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Introduction
11.4.4 Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.4.5 Bellicum Pharmaceuticals Inc Recent Development
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Details
11.5.2 Bristol-Myers Squibb Co Business Overview
11.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Introduction
11.5.4 Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.5.5 Bristol-Myers Squibb Co Recent Development
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Details
11.6.2 bluebird bio Inc Business Overview
11.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Introduction
11.6.4 bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.6.5 bluebird bio Inc Recent Development
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Details
11.7.2 CARsgen Therapeutics Ltd Business Overview
11.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Introduction
11.7.4 CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.7.5 CARsgen Therapeutics Ltd Recent Development
11.8 Celgene Corp
11.8.1 Celgene Corp Company Details
11.8.2 Celgene Corp Business Overview
11.8.3 Celgene Corp Adoptive Cellular Immunotherapy Introduction
11.8.4 Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.8.5 Celgene Corp Recent Development
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Details
11.9.2 Cell Medica Ltd Business Overview
11.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Introduction
11.9.4 Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.9.5 Cell Medica Ltd Recent Development
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Details
11.10.2 Cellular Biomedicine Group Inc Business Overview
11.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Introduction
11.10.4 Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.10.5 Cellular Biomedicine Group Inc Recent Development
11.11 Celularity Inc
11.11.1 Celularity Inc Company Details
11.11.2 Celularity Inc Business Overview
11.11.3 Celularity Inc Adoptive Cellular Immunotherapy Introduction
11.11.4 Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.11.5 Celularity Inc Recent Development
11.12 Celyad SA
11.12.1 Celyad SA Company Details
11.12.2 Celyad SA Business Overview
11.12.3 Celyad SA Adoptive Cellular Immunotherapy Introduction
11.12.4 Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.12.5 Celyad SA Recent Development
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Details
11.13.2 Daiichi Sankyo Co Ltd Business Overview
11.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Introduction
11.13.4 Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.13.5 Daiichi Sankyo Co Ltd Recent Development
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Details
11.14.2 Fosun Pharmaceutical AG Business Overview
11.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Introduction
11.14.4 Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.14.5 Fosun Pharmaceutical AG Recent Development
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Details
11.15.2 Gilead Sciences Inc Business Overview
11.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Introduction
11.15.4 Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.15.5 Gilead Sciences Inc Recent Development
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Details
11.17.2 Hangzhou Converd Co Ltd Business Overview
11.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Introduction
11.17.4 Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.17.5 Hangzhou Converd Co Ltd Recent Development
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
11.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Introduction
11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
11.18 HRAIN Biotechnology Co Ltd
11.25.1 HRAIN Biotechnology Co Ltd Company Details
11.25.2 HRAIN Biotechnology Co Ltd Business Overview
11.25.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.25.4 HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.25.5 HRAIN Biotechnology Co Ltd Recent Development
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Details
11.20.2 Juno Therapeutics Inc Business Overview
11.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
11.20.4 Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.20.5 Juno Therapeutics Inc Recent Development
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Details
11.21.2 Kite Pharma Inc Business Overview
11.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Introduction
11.21.4 Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.21.5 Kite Pharma Inc Recent Development
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Details
11.22.2 Nanjing Legend Biotech Co Ltd Business Overview
11.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Introduction
11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.22.5 Nanjing Legend Biotech Co Ltd Recent Development
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Details
11.23.2 NantKwest Inc Business Overview
11.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Introduction
11.23.4 NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.23.5 NantKwest Inc Recent Development
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Details
11.24.2 Nkarta Inc Business Overview
11.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Introduction
11.24.4 Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.24.5 Nkarta Inc Recent Development
11.25 Novartis AG
11.25.1 Novartis AG Company Details
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Adoptive Cellular Immunotherapy Introduction
11.25.4 Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.25.5 Novartis AG Recent Development
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Details
11.26.2 Ono Pharmaceutical Co Ltd Business Overview
11.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Introduction
11.26.4 Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.26.5 Ono Pharmaceutical Co Ltd Recent Development
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Details
11.28.2 Sorrento Therapeutics Inc Business Overview
11.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
11.28.4 Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.28.5 Sorrento Therapeutics Inc Recent Development
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Details
11.29.2 Takara Bio Inc Business Overview
11.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Introduction
11.29.4 Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021)
11.29.5 Takara Bio Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details